5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors.
Gravina
Giovanni Luca
GL
Division of Radiotherapy, Department of Experimental Medicine, University of L'Aquila, L'Aquila, Italy. giovanniluca.gravina@poste.it
Marampon
Francesco
F
Di Staso
Mario
M
Bonfili
Pierluigi
P
Vitturini
Alessandro
A
Jannini
Emmanuele A
EA
Pestell
Richard G
RG
Tombolini
Vincenzo
V
Festuccia
Claudio
C